~~<i id='6D5C5D53C5'><strike id='6D5C5D53C5'><tt id='6D5C5D53C5'><pre id='6D5C5D53C5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

comprehensive

author：entertainment 2025-08-24 04:11:39 - browse：31956

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Steward Health Care has deal to sell doctor network to UnitedHealth

focus

hotspot

focus

hotspot

entertainment

ArthurAshecompetinginLondonin1968.HultonArchive/GettyImagesDoprominentpublicfigureswhoareillhavesome

WSS

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Merck drug for rare lung condition set for approval in U.S.

Eliminate the waiting period for sterilization covered by Medicaid

Option Care buys Amedisys in $3.6 billion home care deal

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Van's Gluten Free Original Waffles recalled for possible wheat allergen

knowledge

comprehensive

focus

Guidelines to prevent youth baseball injuries need more muscle

Inside the fall of star MIT scientist David Sabatini

Virginia high school admissions case could be legal follow

RaDonda Vaught case: a double standard for nurses, physicians

Tori Bowie and the unacceptable rates of Black maternal death

Covid vaccine financial winners and losers, from Pfizer to Novavax

Continuity nursing helped my family in our darkest PICU moments

Pfizer's Covid pill remains 89% effective in final analysis, company says

United colonoscopy coverage change 'may cost lives,' doctors say

Scientists boost immune system in aging mice by making it youthful

hotspot

Readout LOUD podcast: mifepristone case, GLP

Option Care buys Amedisys in $3.6 billion home care deal

Inside the fall of star MIT scientist David Sabatini

7 people shot in DC, police say

Van's Gluten Free Original Waffles recalled for possible wheat allergen

7 people shot in DC, police say

focus

hotspot

hotspot

entertainment